ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Majori, M
Right arrow Articles by Chanez, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majori, M
Right arrow Articles by Chanez, P
Eur Respir J 1998; 11: 133-138
Copyright © ERS Journals Ltd 1998

Original Articles

Superoxide anion production by monocytes of corticosteroid-treated asthmatic patients

M Majori, I Vachier, P Godard, M Farce, J Bousquet, and P Chanez

Reactive oxygen species play an important role in promoting inflammation. Blood monocytes have been described to release higher amounts of superoxide anion in uncontrolled and untreated asthmatics. Corticosteroids are widely used in asthma, but little is known about their molecular mechanism of action. The aim of our study was to analyse the ex vivo effect of corticosteroid treatments on superoxide anion release by blood monocytes. Superoxide anion release was measured by a spectrophotometric method based on the superoxide dismutase (SOD) -inhibitable reduction of ferricytochrome C by blood monocytes from untreated patients and asthmatics treated with i.v., inhaled and oral corticosteroids. Monocytes from uncontrolled and untreated asthmatics, released high amounts of superoxide anions. After short-term treatment with i.v., corticosteroids, this release was found to decrease significantly (1.410 versus 0.340 nM, p<0.05). Cells from asthmatics who had undergone long-term treatment with inhaled or oral steroids presented low amounts of superoxide anion production, with a significant difference as compared to untreated asthmatics (0.375 nM p<0.01 and 0.620 nM p<0.02 respectively). In general, patients with controlled asthma (treated with short-term oral steroids, or with long-term inhaled steroids) released lesser amounts of superoxide anion than uncontrolled and untreated asthmatics. In the case of steroid-dependent asthmatics there was no difference between patients with a controlled or uncontrolled disease.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. A. A. Comhair, K. S. Ricci, M. Arroliga, A. R. Lara, R. A. Dweik, W. Song, S. L. Hazen, E. R. Bleecker, W. W. Busse, K. F. Chung, et al.
Correlation of Systemic Superoxide Dismutase Deficiency to Airflow Obstruction in Asthma
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 306 - 313.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Bonnans, P. Chanez, H. Meziane, P. Godard, J. Bousquet, and I. Vachier
Glucocorticoid receptor-binding characteristics in severe asthma
Eur. Respir. J., June 1, 2003; 21(6): 985 - 988.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. Bonnans, I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez
Lipoxins Are Potential Endogenous Antiinflammatory Mediators in Asthma
Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1531 - 1535.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Whitekus, N. Li, M. Zhang, M. Wang, M. A. Horwitz, S. K. Nelson, L. D. Horwitz, N. Brechun, D. Diaz-Sanchez, and A. E. Nel
Thiol Antioxidants Inhibit the Adjuvant Effects of Aerosolized Diesel Exhaust Particles in a Murine Model for Ovalbumin Sensitization
J. Immunol., March 1, 2002; 168(5): 2560 - 2567.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.